SynthesisFrontiers in oncology2024

Perioperative immunotherapy for stage II-III non-small cell lung cancer: a meta-analysis base on randomized controlled trials.

Anping Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.